Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DTC Ads Are "Most Accurate" Rx Info Source Due To FDA Oversight - PhRMA

Executive Summary

FDA regulation helps ensure that direct-to-consumer ads are the most reliable prescription drug information available, the Pharmaceutical Research & Manufacturers of America maintains.

You may also be interested in...



Senate DTC hearing

Senate Commerce/Consumer Affairs Subcommittee DTC advertising hearing postponed until July 24. The committee had rescheduled the hearing for July 18 after being delayed May 22 due to floor votes. The witness list will remain the same as the May hearing; FDA's Division of Drug Marketing, Advertising & Communications and the Pharmaceutical Research & Manufacturers of America are among those testifying (1"The Pink Sheet" May 28, p. 9)

Senate DTC hearing

Senate Commerce/Consumer Affairs Subcommittee DTC advertising hearing postponed until July 24. The committee had rescheduled the hearing for July 18 after being delayed May 22 due to floor votes. The witness list will remain the same as the May hearing; FDA's Division of Drug Marketing, Advertising & Communications and the Pharmaceutical Research & Manufacturers of America are among those testifying (1"The Pink Sheet" May 28, p. 9)

Senate DTC hearing

Commerce/Consumer Affairs Subcommittee hearing on direct-to-consumer advertising rescheduled for July 18. Hearing originally was slated for May 22, but was delayed due to floor votes. Session will be held from 2:30 p.m. to 5 p.m. in Russell Senate Office Building room 253

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037899

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel